FDA
FDA Pushes Enrollment of Underrepresented Populations in Clinical Trials with Recent ‘Race and Ethnicity Diversity Plan’ Draft Guidance
Jacob Simpson
...
Why Do Clinical Trials Still Underrepresent Minority Groups?
It’s no secret that, for decades, the participants in clinical trials for new drugs and medical devices haven’t accurately represented ...
VCU expert: FDA proposed ban on menthol cigarettes ‘historic and long overdue’ - VCU News
Mignonne Guy, Ph.D., said the FDA’s proposal to ban menthol cigarettes would save lives, particularly those of Black Americans. (Getty Images)
&#...
FDA proposes adding ‘race and ethnicity’ category to expanded access requests – Endpoints News
It’s well understood that racial and ethnic minorities often lack access to clinical trials in the US, either because of restricted i...
FDA increases racial and ethnic diversity in clinical trials
FDA issued a draft guidance document for developi...
FDA OCE commentary: Cancer burden facing Asian Americans partly caused by racism
A commentary authored by seven researchers who participated in the FDA Oncology Center of Excellence “Conversations on Cancer,” held July 29, 2021,...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
